Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations.
Kodjikian L, Parravano M, Clemens A, Dolz-Marco R, Holz FG, Munk MR, Nicolò M, Ricci F, Silva R, Talks SJ, Verma RK, Zarranz-Ventura J, Zweifel SA. Kodjikian L, et al. Among authors: nicolo m. Eye (Lond). 2021 Aug;35(8):2119-2135. doi: 10.1038/s41433-021-01487-0. Epub 2021 Apr 1. Eye (Lond). 2021. PMID: 33795837 Free PMC article. Review.
Efficacy of a New Commercial Ocular Spray Containing Oftasecur Citrus Extract for Reducing Microbial Load in the Conjunctiva of Patients Receiving Intravitreal Injections.
Vagge A, Ferro Desideri L, Carnevali A, Del Noce C, Camposampiero D, Agrusta M, Ponzin D, Pellegrini M, Vaccaro S, Nicolò M, Scorcia V, Traverso CE, Giannaccare G. Vagge A, et al. Among authors: nicolo m. Ophthalmol Ther. 2021 Dec;10(4):1025-1032. doi: 10.1007/s40123-021-00384-9. Epub 2021 Sep 8. Ophthalmol Ther. 2021. PMID: 34495493 Free PMC article.
Retinal Pigment Epithelium Tear after Glaucoma Surgery.
Cutolo CA, Nicolò M, Traverso CE. Cutolo CA, et al. Among authors: nicolo m. Ophthalmology. 2022 Jan;129(1):110. doi: 10.1016/j.ophtha.2021.05.027. Ophthalmology. 2022. PMID: 34930547 No abstract available.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
205 results